Immune Reset to Help Highly Sensitized Kidney Transplant Patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a special immune-resetting treatment can help patients who have developed too many antibodies against donor kidneys get access to a compatible kidney transplant. The treatment uses chemotherapy and stem cell transplantation to 'reset' your immune system so it stops rejecting potential donor kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–60 years old
- You have end-stage kidney disease and are currently on dialysis
- You are highly sensitized (have very high levels of antibodies against donor kidneys, typically ≥95%)
- You are currently on a deceased-donor kidney transplant waiting list
- Your heart, lungs, liver, and bone marrow are healthy enough to safely handle strong chemotherapy and stem cell transplantation
- You can understand the study and commit to long-term follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new CAR-T therapy that targets immune cells to reduce harmful antibodies in highly sensitized kidney transplant candidates. The goal is to help your body accept a kidney from a donor that would otherwise be rejected.
This trial tests a new drug, OM336, to reduce antibodies that make it hard to find a matching kidney for transplant. It may help people who have been waiting a long time for a kidney or who have a living donor but their antibodies attack the donor kidney.
This trial tests a drug called BiTE to reduce high antibody levels (cPRA ≥90%) in people waiting for a kidney transplant. If it works, it might help you become eligible for a transplant sooner.
This trial tests if a special stem cell treatment (using your own stem cells) can reset your immune system so you can accept a kidney from a deceased donor, even if you have very high antibody levels that make it hard to find a match. It's for people who have been waiting a long time and haven't had a transplant offer.
This trial tests a new treatment using your own immune cells, called tolerogenic dendritic cells, to help your body accept a kidney transplant. It is designed for people who are highly sensitized and have a very hard time finding a matching donor kidney.
This Phase 1 study tests a treatment plan given after a kidney transplant to help the immune system stay calm and reduce the risk of rejection. Participants must have a well-functioning kidney transplant from a closely matched living donor and meet health and safety requirements.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.